InvestorsHub Logo
Followers 743
Posts 61839
Boards Moderated 10
Alias Born 10/05/2009

Re: sanosurfer post# 89

Friday, 03/12/2010 10:05:03 AM

Friday, March 12, 2010 10:05:03 AM

Post# of 1435
Good call, morning news says the merger is complete:

http://eresearch.fidelity.com/eresearch/goto/evaluate/news/basicNewsStory.jhtml?symbols=MHAN&product=FULLFEED&provider=PRIMZONE&storyid=201003120735PRIMZONEFULLFEED186463&hlinks=vnhl

.

In addition, Manhattan Pharmaceuticals has reserved 43.63 million shares of its common stock for the possible future conversion of $16.45 million of Ariston's outstanding convertible debt. The debt holders have no recourse to Manhattan Pharmaceuticals for repayment. They do have the right to convert their notes into shares of Manhattan Pharmaceuticals common stock.

That works out to a debt to stock conversion price of 37.7 cents/share.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TGTX News